Mayinglong Pharmaceutical Group Co (SHSE:600993) Institutional Ownership: 22.03% (As of Aug. 12, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600993 Mayinglong Pharmaceutical Group Co Ltd SHSE:600993
84 GF Score
Price ¥23.50
GF Value ¥29.22
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Mayinglong Pharmaceutical Group Co Institutional Ownership?

Mayinglong Pharmaceutical Group Co SHSE:600993 -1.34% 84 Institutional Ownership is 22.03% as of Aug. 12, 2026. GuruFocus rates SHSE:600993 with a GF Score™ of 84/100 and a GF Value™ of ¥29.22 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mayinglong Pharmaceutical Group Co's institutional ownership is 22.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mayinglong Pharmaceutical Group Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mayinglong Pharmaceutical Group Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Mayinglong Pharmaceutical Group Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Mayinglong Pharmaceutical Group Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mayinglong Pharmaceutical Group Co Institutional Ownership Chart

Mayinglong Pharmaceutical Group Co Historical Data

The historical data trend for Mayinglong Pharmaceutical Group Co can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 22.87 22.58 22.03 22.03 22.03 22.01 22.01 22.01 22.03 22.03
SHSE:600993
84GF Score
Mayinglong Pharmaceutical Group Co Ltd SHSE:600993
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mayinglong Pharmaceutical Group Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 22.03% mean?
Mayinglong Pharmaceutical Group Co (SHSE:600993) has a Institutional Ownership of 22.03% as of Aug. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Mayinglong Pharmaceutical Group Co and its competitors.
Is Mayinglong Pharmaceutical Group Co's Institutional Ownership too high?
Mayinglong Pharmaceutical Group Co's current Institutional Ownership is 22.03%. Overall, Mayinglong Pharmaceutical Group Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mayinglong Pharmaceutical Group Co's Institutional Ownership compare to ZTS?
Mayinglong Pharmaceutical Group Co's Institutional Ownership of 22.03% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Mayinglong Pharmaceutical Group Co and its competitors. Mayinglong Pharmaceutical Group Co's current Institutional Ownership is 22.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayinglong Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co (SHSE:600993) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.22, compared to a current price of ¥23.50 — trading 19.6% below its estimated fair value. The current Institutional Ownership is 22.03%. Mayinglong Pharmaceutical Group Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Mayinglong Pharmaceutical Group Co (SHSE:600993), the current Institutional Ownership is 22.03% as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mayinglong Pharmaceutical Group Co (SHSE:600993) Overvalued in 2026?

Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥23.50 is trading 19.6% below its estimated GF Value™ of ¥29.22. GuruFocus considers Mayinglong Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600993:

  • Institutional Ownership: 22.03%
  • GF Value™: ¥29.22 vs. price of ¥23.50 (19.6% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the SHSE:600993 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mayinglong Pharmaceutical Group Co Business Description

Address No. 100 Zhoujiawan, Nanhu, Wuchang District, Wuhan, Hubei, CHN, 430064
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly involved in pharmaceutical development, retailing and wholesaling. The company provides ointments, suppositories, and tablets for hemorrhoids.
84GF Score

Get the complete analysis for SHSE:600993

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.50
Price
¥29.22
GF Value